- Manuel A. Ferreira
(QIMR Berghofer Medical Research Institute)
- Eric R. Gamazon
(Vanderbilt University
University of Cambridge)
- Fares Al-Ejeh
(QIMR Berghofer Medical Research Institute)
- Kristiina Aittomäki
(University of Helsinki)
- Irene L. Andrulis
(Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
University of Toronto)
- Hoda Anton-Culver
(University of California Irvine)
- Adalgeir Arason
(Landspitali University Hospital
University of Iceland)
- Volker Arndt
(German Cancer Research Center (DKFZ))
- Kristan J. Aronson
(Queen’s University)
- Banu K. Arun
(University of Texas MD Anderson Cancer Center)
- Ella Asseryanis
(Medical University of Vienna)
- Jacopo Azzollini
(Fondazione IRCCS Istituto Nazionale dei Tumori (INT))
- Judith Balmaña
(Vall dHebron Institute of Oncology (VHIO)
University Hospital)
- Daniel R. Barnes
(University of Cambridge)
- Daniel Barrowdale
(University of Cambridge)
- Matthias W. Beckmann
(Friedrich-Alexander-University Erlangen-Nuremberg)
- Sabine Behrens
(German Cancer Research Center (DKFZ))
- Javier Benitez
(Centro de Investigación en Red de Enfermedades Raras (CIBERER)
Spanish National Cancer Research Centre (CNIO))
- Marina Bermisheva
(Ufa Federal Research Centre of Russian Academy of Sciences)
- Katarzyna Białkowska
(Pomeranian Medical University)
- Carl Blomqvist
(University of Helsinki
Örebro University Hospital)
- Natalia V. Bogdanova
(Hannover Medical School
Hannover Medical School
N.N. Alexandrov Research Institute of Oncology and Medical Radiology)
- Stig E. Bojesen
(Herlev and Gentofte Hospital, Copenhagen University Hospital
Copenhagen University Hospital
University of Copenhagen)
- Manjeet K. Bolla
(University of Cambridge)
- Ake Borg
(Lund University and Skåne University Hospital)
- Hiltrud Brauch
(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
University of Tübingen
German Cancer Research Center (DKFZ))
- Hermann Brenner
(German Cancer Research Center (DKFZ)
German Cancer Research Center (DKFZ)
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT))
- Annegien Broeks
(The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital)
- Barbara Burwinkel
(German Cancer Research Center (DKFZ)
University Womens Clinic Heidelberg, University of Heidelberg)
- Trinidad Caldés
(IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos))
- Maria A. Caligo
(University Hospital of Pisa)
- Daniele Campa
(German Cancer Research Center (DKFZ)
University of Pisa)
- Ian Campbell
(Peter MacCallum Cancer Center
The University of Melbourne)
- Federico Canzian
(German Cancer Research Center (DKFZ))
- Jonathan Carter
(Chris O’Brien Lifehouse and The University of Sydney)
- Brian D. Carter
(American Cancer Society)
- Jose E. Castelao
(Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS)
- Jenny Chang-Claude
(German Cancer Research Center (DKFZ)
University Medical Center Hamburg-Eppendorf)
- Stephen J. Chanock
(Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services)
- Hans Christiansen
(Hannover Medical School)
- Wendy K. Chung
(Columbia University)
- Kathleen B. M. Claes
(Ghent University)
- Christine L. Clarke
(University of Sydney)
- Fergus J. Couch
(Mayo Clinic)
- Angela Cox
(University of Sheffield)
- Simon S. Cross
(University of Sheffield)
- Kamila Czene
(Karolinska Institutet)
- Mary B. Daly
(Fox Chase Cancer Center)
- Miguel Hoya
(IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos))
- Joe Dennis
(University of Cambridge)
- Peter Devilee
(Leiden University Medical Center
Leiden University Medical Center)
- Orland Diez
(Vall dHebron Institute of Oncology (VHIO)
University Hospital Vall dHebron)
- Thilo Dörk
(Hannover Medical School)
- Alison M. Dunning
(University of Cambridge)
- Miriam Dwek
(University of Westminster)
- Diana M. Eccles
(University of Southampton)
- Bent Ejlertsen
(Copenhagen University Hospital)
- Carolina Ellberg
(Lund University)
- Christoph Engel
(University of Leipzig)
- Mikael Eriksson
(Karolinska Institutet)
- Peter A. Fasching
(Friedrich-Alexander-University Erlangen-Nuremberg
University of California at Los Angeles)
- Olivia Fletcher
(The Institute of Cancer Research)
- Henrik Flyger
(Copenhagen University Hospital)
- Eitan Friedman
(Chaim Sheba Medical Center
Tel Aviv University)
- Debra Frost
(University of Cambridge)
- Marike Gabrielson
(Karolinska Institutet)
- Manuela Gago-Dominguez
(Complejo Hospitalario Universitario de Santiago, SERGAS
University of California San Diego)
- Patricia A. Ganz
(Jonsson Comprehensive Cancer Centre, UCLA)
- Susan M. Gapstur
(American Cancer Society)
- Judy Garber
(Dana-Farber Cancer Institute)
- Montserrat García-Closas
(Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services
Institute of Cancer Research)
- José A. García-Sáenz
(Centro Investigación Biomédica en Red de Cáncer (CIBERONC))
- Mia M. Gaudet
(American Cancer Society)
- Graham G. Giles
(Cancer Council Victoria
The University of Melbourne
Monash University)
- Gord Glendon
(Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital)
- Andrew K. Godwin
(Kansas University Medical Center)
- Mark S. Goldberg
(McGill University
McGill University)
- David E. Goldgar
(University of Utah School of Medicine)
- Anna González-Neira
(Spanish National Cancer Research Centre (CNIO))
- Mark H. Greene
(National Cancer Institute)
- Jacek Gronwald
(Pomeranian Medical University)
- Pascal Guénel
(University Paris-Saclay)
- Christopher A. Haiman
(University of Southern California)
- Per Hall
(Karolinska Institutet
Södersjukhuset)
- Ute Hamann
(German Cancer Research Center (DKFZ))
- Wei He
(Karolinska Institutet)
- Jane Heyworth
(The University of Western Australia)
- Frans B. L. Hogervorst
(The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital)
- Antoinette Hollestelle
(Erasmus MC Cancer Institute)
- Robert N. Hoover
(Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services)
- John L. Hopper
(The University of Melbourne)
- Peter J. Hulick
(NorthShore University HealthSystem
The University of Chicago Pritzker School of Medicine)
- Keith Humphreys
(Karolinska Institutet)
- Evgeny N. Imyanitov
(N.N. Petrov Institute of Oncology. St.)
- Claudine Isaacs
(Georgetown University)
- Milena Jakimovska
(Macedonian Academy of Sciences and Arts)
- Anna Jakubowska
(Pomeranian Medical University
Pomeranian Medical University)
- Paul A. James
(The University of Melbourne
Peter MacCallum Cancer Center)
- Ramunas Janavicius
(Vilnius University Hospital Santariskiu Clinics)
- Rachel C. Jankowitz
(University of Pittsburgh School of Medicine)
- Esther M. John
(Stanford University School of Medicine)
- Nichola Johnson
(The Institute of Cancer Research)
- Vijai Joseph
(Memorial Sloan-Kettering Cancer Center)
- Beth Y. Karlan
(University of California at Los Angeles)
- Elza Khusnutdinova
(Ufa Federal Research Centre of Russian Academy of Sciences
Bashkir State Medical University)
- Johanna I. Kiiski
(Helsinki University Hospital, University of Helsinki)
- Yon-Dschun Ko
(Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus)
- Michael E. Jones
(The Institute of Cancer Research)
- Irene Konstantopoulou
(National Centre for Scientific Research ‘Demokritos’)
- Vessela N. Kristensen
(Oslo University Hospital-Radiumhospitalet
University of Oslo)
- Yael Laitman
(Chaim Sheba Medical Center)
- Diether Lambrechts
(VIB Center for Cancer Biology, VIB
University of Leuven)
- Conxi Lazaro
(ICO-IDIBELL (Bellvitge Biomedical Research Institute, Catalan Institute of Oncology), CIBERONC)
- Goska Leslie
(University of Cambridge)
- Jenny Lester
(University of California at Los Angeles)
- Fabienne Lesueur
(Genetic Epidemiology of Cancer team, Inserm U900
Institut Curie
Mines ParisTech)
- Sara Lindström
(University of Washington School of Public Health
Fred Hutchinson Cancer Research Center)
- Jirong Long
(Vanderbilt University School of Medicine)
- Jennifer T. Loud
(National Cancer Institute)
- Jan Lubiński
(Pomeranian Medical University)
- Enes Makalic
(The University of Melbourne)
- Arto Mannermaa
(University of Eastern Finland
University of Eastern Finland
Kuopio University Hospital)
- Mehdi Manoochehri
(German Cancer Research Center (DKFZ))
- Sara Margolin
(Södersjukhuset
Södersjukhuset, Karolinska Institutet)
- Tabea Maurer
(University Medical Center Hamburg-Eppendorf)
- Dimitrios Mavroudis
(University Hospital of Heraklion)
- Lesley McGuffog
(University of Cambridge)
- Alfons Meindl
(University of Munich, Campus Großhadern)
- Usha Menon
(University College London)
- Kyriaki Michailidou
(University of Cambridge
The Cyprus Institute of Neurology & Genetics)
- Austin Miller
(Roswell Park Cancer Institute)
- Marco Montagna
(Veneto Institute of Oncology IOV - IRCCS)
- Fernando Moreno
(Centro Investigación Biomédica en Red de Cáncer (CIBERONC))
- Lidia Moserle
(Veneto Institute of Oncology IOV - IRCCS)
- Anna Marie Mulligan
(University of Toronto
University Health Network)
- Katherine L. Nathanson
(University of Pennsylvania)
- Susan L. Neuhausen
(Beckman Research Institute of City of Hope)
- Heli Nevanlinna
(Helsinki University Hospital, University of Helsinki)
- Ines Nevelsteen
(University Hospitals Leuven)
- Finn C. Nielsen
(Copenhagen University Hospital)
- Liene Nikitina-Zake
(Latvian Biomedical Research and Study Centre)
- Robert L. Nussbaum
(University of California San Francisco)
- Kenneth Offit
(Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center)
- Edith Olah
(National Institute of Oncology)
- Olufunmilayo I. Olopade
(The University of Chicago)
- Håkan Olsson
(Lund University)
- Ana Osorio
(Centro de Investigación en Red de Enfermedades Raras (CIBERER)
Spanish National Cancer Research Centre (CNIO))
- Janos Papp
(National Institute of Oncology)
- Tjoung-Won Park-Simon
(Hannover Medical School)
- Michael T. Parsons
(QIMR Berghofer Medical Research Institute)
- Inge Sokilde Pedersen
(Aalborg University Hospital
Aalborg University Hospital
Aalborg University)
- Ana Peixoto
(Portuguese Oncology Institute)
- Paolo Peterlongo
(Genome Diagnostics Program, IFOM - the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology)
- Paul D. P. Pharoah
(University of Cambridge
University of Cambridge)
- Dijana Plaseska-Karanfilska
(Macedonian Academy of Sciences and Arts)
- Bruce Poppe
(Ghent University)
- Nadege Presneau
(University of Westminster)
- Paolo Radice
(Fondazione IRCCS Istituto Nazionale dei Tumori (INT))
- Johanna Rantala
(Karolinska Institutet)
- Gad Rennert
(Carmel Medical Center and Technion Faculty of Medicine)
- Harvey A. Risch
(Yale School of Public Health)
- Emmanouil Saloustros
(University Hospital of Larissa)
- Kristin Sanden
(City of Hope Clinical Cancer Genetics Community Research Network)
- Elinor J. Sawyer
(Guy’s Hospital, King’s College London)
- Marjanka K. Schmidt
(The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital)
- Rita K. Schmutzler
(University of Cologne
University of Cologne)
- Priyanka Sharma
(University of Kansas Medical Center)
- Xiao-Ou Shu
(Vanderbilt University School of Medicine)
- Jacques Simard
(Centre Hospitalier Universitaire de Québec – Université Laval, Research Center)
- Christian F. Singer
(Medical University of Vienna)
- Penny Soucy
(Centre Hospitalier Universitaire de Québec – Université Laval, Research Center)
- Melissa C. Southey
(Monash University
The University of Melbourne)
- John J. Spinelli
(BC Cancer
University of British Columbia)
- Amanda B. Spurdle
(QIMR Berghofer Medical Research Institute)
- Jennifer Stone
(The University of Melbourne
Curtin University and University of Western Australia)
- Anthony J. Swerdlow
(The Institute of Cancer Research
The Institute of Cancer Research)
- William J. Tapper
(University of Southampton)
- Jack A. Taylor
(NIH
National Institute of Environmental Health Sciences, NIH)
- Manuel R. Teixeira
(Portuguese Oncology Institute
University of Porto)
- Mary Beth Terry
(Columbia University)
- Alex Teulé
(IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, CIBERONC)
- Mads Thomassen
(Odense University Hospital)
- Kathrin Thöne
(University Medical Center Hamburg-Eppendorf)
- Darcy L. Thull
(University of Pittsburgh School of Medicine)
- Marc Tischkowitz
(McGill University
University of Cambridge)
- Amanda E. Toland
(The Ohio State University)
- Diana Torres
(German Cancer Research Center (DKFZ)
Pontificia Universidad Javeriana)
- Thérèse Truong
(University Paris-Saclay)
- Nadine Tung
(Beth Israel Deaconess Medical Center)
- Celine M. Vachon
(Mayo Clinic)
- Christi J. Asperen
(Leiden University Medical Center)
- Ans M. W. Ouweland
(Erasmus University Medical Center)
- Elizabeth J. Rensburg
(University of Pretoria)
- Ana Vega
(CIBERER, IDIS)
- Alessandra Viel
(Centro di Riferimento Oncologico di Aviano (CRO), IRCCS)
- Qin Wang
(University of Cambridge)
- Barbara Wappenschmidt
(University of Cologne
University of Cologne)
- Jeffrey N. Weitzel
(Clinical Cancer Genomics, City of Hope)
- Camilla Wendt
(Södersjukhuset, Karolinska Institutet)
- Robert Winqvist
(University of Oulu
Northern Finland Laboratory Centre Oulu)
- Xiaohong R. Yang
(Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services)
- Drakoulis Yannoukakos
(National Centre for Scientific Research ‘Demokritos’)
- Argyrios Ziogas
(University of California Irvine)
- Peter Kraft
(Harvard T.H. Chan School of Public Health
Harvard T.H. Chan School of Public Health)
- Antonis C. Antoniou
(University of Cambridge)
- Wei Zheng
(Vanderbilt University School of Medicine)
- Douglas F. Easton
(University of Cambridge
University of Cambridge)
- Roger L. Milne
(Cancer Council Victoria
The University of Melbourne
Monash University)
- Jonathan Beesley
(QIMR Berghofer Medical Research Institute)
- Georgia Chenevix-Trench
(QIMR Berghofer Medical Research Institute)